Close X
Wednesday, December 4, 2024
ADVT 
International

Indian Embassy issues advisory to Indian medical students in China

Darpan News Desk IANS, 07 Nov, 2022 04:22 PM
  • Indian Embassy issues advisory to Indian medical students in China

New Delhi, Nov 7 (IANS) Indian students, who had joined the clinical medicine programme in China after November 2021 but had failed to secure license to practice as a medical doctor there, won't be eligible to appear in the Foreign Medical Graduate Examination, conducted by National Medical Commission, the Indian Embassy in Beijing said on Monday.

"The embassy has apprised the Chinese authorities concerned and medical colleges with a request that they should ensure that all Indian students coming to China for clinical medicine programme are educated, trained and facilitated, so that they can fulfill the requirements of the NMC," an embassy statement said.

The clarification from the embassy came after queries raised by students and parents regarding eligibility of those Indian students who are pursuing clinical medicine programme in China, for appearing in the qualifying examination in India.

"In this regard, the students and their parents are requested to see the Gazette Notification dated November 18, 2021, by the NMC. It has unambiguously stated in Clause 4(b) that foreign medical students must be 'registered with the respective professional regulatory body or otherwise, competent to grant license to practice medicine in their respective jurisdiction of the country in which the medical degree is awarded and at par with the license to practice medicine given to citizen of that country'," the embassy said.

Queries had also been received by the Indian Embassy on whether Indian students could work in Chinese hospitals as "assistant doctor" after completing their medical education in China but fail to obtain medical practitioner license in China. This would help them to earn a living and pay back education loans.

On this, the embassy said that it "has formally approached relevant Chinese authorities to confirm existence of such an option. The embassy will share any information, when received from the Chinese side, in its social media handles".

Prospective students and parents are advised to directly re-confirm all terms of reference of admission directly from the relevant universities in China, before accepting such admission, the statement added.

Photo courtesy of Wikipedia. 

MORE International ARTICLES

Trump formally lets Canadian aluminum off hook

Trump formally lets Canadian aluminum off hook
The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel